Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0251
+0.0002 (0.97%)
Jul 6, 2026, 1:09 PM EST
Bioxytran Market Cap
Bioxytran has a market cap or net worth of $2.85 million as of July 6, 2026. Its market cap has decreased by -73.30% in one year.
Market Cap
2.85M
Enterprise Value
3.64M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 2.85M, a decrease of -88.83%. That is a compound annual growth rate of -24.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 2.85M | -65.02% |
| Dec 31, 2025 | 8.15M | 4.49% |
| Dec 31, 2024 | 7.80M | -64.29% |
| Dec 29, 2023 | 21.85M | -63.00% |
| Dec 30, 2022 | 59.05M | 33.18% |
| Dec 31, 2021 | 44.34M | 89.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Software | 3.44M |
| Eastgate Biotech | 3.17M |
| CASI Pharmaceuticals | 3.02M |
| Vaccinex | 2.73M |
| Iterum Therapeutics | 2.64M |
| Institute of Biomedical Research | 2.58M |
| AccuStem Sciences | 2.51M |
| Hepion Pharmaceuticals | 2.44M |